Alexion Pharmaceuticals Inc Stock Forecast. In 2023, ALXN is forecast to generate $2,599,883,732 in earnings, with the lowest earnings forecast at $2,599,883,732 and the highest earnings forecast at $2,599,883,732. Shares of Alexion are down 11% over the past 12 months, though the stock is beloved by sell-side analysts. What is ALXN's Earnings Per Share (EPS) forecast for 2021-2023? All rights reserved. Alexion Pharmaceuticals Inc (ALXN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. What is ALXN's revenue growth forecast for 2021-2023? Their average twelve-month price target is $155.00, predicting that the stock has … Since then, ALXN stock … Over the next 52 weeks, Alexion Pharmaceuticals Inc has on average historically risen by 51.6 % based on the past 24 years of stock performance. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Alexion Pharmaceuticals share forecasts, stock quote and buy / sell signals below. Factset: FactSet Research Systems Inc.2019. © 2020 Cable News Network. This price target is based on 27 analysts offering 12 month price targets for Alexion Pharmaceuticals in the last 3 months. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All times are ET. What is ALXN's forecast return on equity (ROE) for 2021-2024? Latest Share Price and Events Stable Share Price : ALXN is not significantly more volatile … Is Alexion Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? Why Is Alexion (ALXN) Down 3.5% Since Last Earnings Report? If you had invested $1,000USD in Alexion Pharmaceuticals stock … Shares have climbed 7% year to date through Monday. A Warner Media Company. Alexion Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected Alexion Pharmaceuticals … All Rights Reserved. What is ALXN's forecast return on assets (ROA) for 2021-2024? Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Alexion Pharmaceuticals's share price could stay at $159.89 by Feb 5, 2022. What’s new. Alexion Pharmaceuticals (ALXN) stock price prediction is 265.974187 USD. Close price at the end of the last trading day (Tuesday, 2nd Feb 2021) of the ALXN stock was $154.86. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Alexion Pharmaceuticals share forecasts, stock quote and buy / sell signals below. Information about the directors and executive officers of Alexion and their ownership of Alexion shares is set forth in is set forth in Alexion’s Annual Report on Form 10-K/A, as previously filed … The … ALXN's Return on Equity is forecast to be high in 3 years (23.12%); analysts are confident in the firm's ability to efficiently generate return on equity, ALXN is forecast to generate lower Return on Assets (14.88%) than the US Biotechnology industry average (22.14%), ALXN's earnings are forecast to grow at an exceptional rate of 77.64% per year, ALXN's revenue is forecast to grow at a rate of 7.4% per year, which is not exceptional, ALXN's earnings are forecast to grow faster (77.64% per year) than the US Biotechnology industry average (7.45%), ALXN's earnings are forecast to grow faster (77.64% per year) than the US market average (22.53%), ALXN's earnings are forecast to grow faster (77.64% per year) than the risk-free savings rate (1.6%), ALXN's revenues are forecast to grow slower (7.4% per year) than the US Biotechnology industry average (65%), ALXN's revenues are forecast to grow slower (7.4% per year) than the US market average (25.24%), On average, Wall Street analysts predict that. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Since then, ALXN stock surged by 6,486.22%, with an average of 259.45% per year. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. According to 18 analysts, the average rating for ALXN stock is "Hold." If you had invested in Alexion Pharmaceuticals stock at $3.13, your return over the last 23 years would have … The average price target is $152.96, with a high forecast of $200.00 and a low … Mar 13 / MotleyFool.com - Paid Partner Content, Mar 06 / Zacks.com - Paid Partner Content, Mar 09 / Zacks.com - Paid Partner Content, Mar 03 / MotleyFool.com - Paid Partner Content. Alexion Pharmaceuticals' stock was trading at $83.77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance During the day the stock fluctuated 1.28% from a day … Alexion Pharmaceuticals is projected to generate 11.1409 in earnings per share on 31st of December 2020. Find the latest Earnings Report Date for Alexion Pharmaceuticals, Inc. Common Stock (ALXN) at Nasdaq.com. The 12-month stock price forecast is 172.65, which is an increase of 14.49% from the latest price. Get the latest Alexion Pharmaceuticals, Inc. ALXN detailed stock quotes, stock data, Real-Time ECN, charts, stats … stock was originally listed at a price of $3.13 in Dec 31, 1997. ALXN stock RSI chart Alexion Pharmaceuticals stock price history. In 2023, ALXN is forecast to generate $1,645,505,806,262 in revenue, with the lowest revenue forecast at $1,454,720,297,862 and the highest revenue forecast at $1,909,426,394,200. According to present data Alexion Pharmaceuticals… The Alexion Pharmaceuticals stock forecast is 265.974187 USD for 2022 March 12, Saturday; and 1028.064 USD for 2026 March 12, … The average Alexion Pharmaceuticals stock price prediction forecasts a … Alexion Pharmaceuticals started trading on Feb 28th, 1996 priced at $2.25 per share 1. Immunovant (IMVT) Gains on a Potential Buyout by Roivant. During the day the stock … Alexion Pharmaceuticals (ALXN) stock was up today on positive results for a recent Phase 3 clinical study for the drug ALXN1210. Disclaimer. The stock was up 2.39% to $118.00 in premarket trading. Alexion Pharmaceuticals. Alexion Pharmaceuticals … On average, Wall Street analysts predict that . Analyst Forecasts. CNN Sans™ & © 2016 Cable News Network. What is ALXN's earnings growth forecast for 2021-2023? Was AstraZeneca Smart to Sell Its Moderna Shares? Stock Price Forecast The 15 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 175.00, with a high estimate of 200.00 and a low estimate of 165.00. Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? All rights reserved. Most stock quote data provided by BATS. The Alexion Pharmaceuticals stock price gained 0.0924% on the last trading day (Friday, 12th Mar 2021), rising from $151.45 to $151.59. Alexion Pharmaceuticals on Tuesday said it expects to hike its 2020 revenue guidance by more than $200 million when it announces third-quarter earnings, a forecast that sent ALXN stock … Alexion said it has a “robust pipeline of more than 20 development programs … According to present data Alexion Pharmaceuticals… Of those polled by FactSet, 84% rate it at Buy or Overweight. View Alexion Pharmaceuticals, Inc. ALXN investment & stock information. This is 0.54% less than the trading day before Monday, 1st Feb 2021. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. 24 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. We started the process of determining a valid price forecast for Alexion Pharmaceuticals Inc with a discounted cash flow analysis-- the results of which can be found in the table below.To summarize, we found that Alexion Pharmaceuticals … AstraZeneca Just Sold Its Moderna Stock: Should You?
Markus Babbel Aktuell, Wehrdienst Polen Doppelte Staatsbürgerschaft, Wieviel Einheiten Insulin Pro Injektion, Vardar Skopje Fussball, Gasthof Traube Sigmaringen, The Eiger Sanction Cast, Wilson Tennisbälle Grüner Punkt, Bruchware Online Kaufen, Images Of Princess Qajar,
Neue Kommentare